IP Library › Assignment 062841/0665
Patent Assignment
Reel/Frame 062841/0665

Change of Name

Recorded: 2023-02-23 Pages: 9
Assignor
Assignee
TRANSTHERA SCIENCES (NANJING), INC.
FLOOR 3, BUILDING 9, PHASE 2 ACCELERATOR, BIOTECH AND PHARMACEUTICAL VALLEY, JIANGBEI NEW AREA, NANJING, 210032, CHINA
Covered Properties (6)
Multi-Kinase Inhibitor Compound, and Crystal Form and Use Thereof
Application: 16/156,371 →
Publication: US 2019/0040064
Multi-Kinase Inhibitor Compound, and Crystal Form and Use Thereof
Application: 16/257,342 →
Publication: US 2019/0152972
Inhibitors of Fibroblast Growth Factor Receptor and Use Thereof
Application: 16/328,817 →
Publication: US 2019/0209564
PDE9 Inhibitor and Use Thereof
Application: 16/702,711 →
Publication: US 2020/0115384
Method for Treating a Cancer Mediated by Abnormality of Multi-Kinases
Application: 17/139,452 →
Publication: US 2021/0130354
PDE9 Inhibitor and Use Thereof
Application: 17/141,385 →
Publication: US 2021/0130366
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 11, 2018
From: WU, FRANK
To: NANJING TRANSTHERA BIOSCIENCES CO. LTD.
Reel/Frame 047133/0886 →
Assignment of Assignor's Interest Jan 25, 2019
From: WU, FRANK
To: NANJING TRANSTHERA BIOSCIENCES CO. LTD.
Reel/Frame 048134/0721 →
Assignment of Assignor's Interest Feb 28, 2019
From: WU, FRANK
To: NANJING TRANSTHERA BIOSCIENCES CO. LTD.
Reel/Frame 048464/0317 →
Assignment of Assignor's Interest Dec 4, 2019
From: WU, FRANK; LI, LIN; YANG, XIAOJU
To: NANJING TRANSTHERA BIOSCIENCES CO. LTD.
Reel/Frame 051179/0130 →
Assignment of Assignor's Interest Jan 6, 2021
From: WU, FRANK
To: NANJING TRANSTHERA BIOSCIENCES CO. LTD.
Reel/Frame 054824/0966 →
Assignment of Assignor's Interest Jan 6, 2021
From: WU, FRANK; LI, LIN; YANG, XIAOJU
To: NANJING TRANSTHERA BIOSCIENCES CO. LTD.
Reel/Frame 054826/0493 →